{"id":5931,"date":"2025-01-06T09:43:54","date_gmt":"2025-01-06T08:43:54","guid":{"rendered":"https:\/\/crcm-marseille.fr\/our-technology-platforms\/single-domain-antibody-platform\/"},"modified":"2025-11-18T10:37:11","modified_gmt":"2025-11-18T09:37:11","slug":"single-domain-antibodies","status":"publish","type":"page","link":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/","title":{"rendered":"Single domain antibodies"},"content":{"rendered":"\n<figure class=\"wp-block-image\"><a href=\"https:\/\/crcm-marseille.fr\/en\/\"><img decoding=\"async\" src=\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847\" alt=\"logo-crcm\"\/><\/a><\/figure>\n\n\n\n<ul id=\"menu-main-menu\" class=\"wp-block-list\">\n<li><a href=\"https:\/\/crcm-marseille.fr\/en\/\">Home<\/a><\/li>\n\n\n\n<li><a>Our center<\/a><\/li>\n\n\n\n<li><a>Our research<\/a><\/li>\n\n\n\n<li><a>For students<\/a><\/li>\n\n\n\n<li><a>For scientists<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/crcm-marseille.fr\/our-research-teams\/\">The research teams<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibody-platform\/#\"><\/a><\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/crcm-marseille.fr\/wp-content\/plugins\/sitepress-multilingual-cms\/res\/flags\/en.svg\" alt=\"English\"\/><\/figure>\n\n\n\n<h1 class=\"wp-block-heading\">Nanobodies<\/h1>\n\n\n\n<p>Luminy<\/p>\n\n\n\n<figure class=\"wp-block-image\"><a class=\" mfn-coverimg-wrapper\" href=\"https:\/\/crcm-marseille.fr\/team\/patrick-chames\/\"><img decoding=\"async\" src=\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/12\/Patrick-Chames.jpg\" alt=\"\"\/><\/a><\/figure>\n\n\n\n<p><a href=\"https:\/\/crcm-marseille.fr\/team\/patrick-chames\/\">Patrick Chames<\/a><\/p>\n\n\n\n<p>Platform manager<\/p>\n\n\n\n<h6 class=\"wp-block-heading\">The mission of the Nanobodies platform&nbsp;is to help research teams isolate single-domain antibodies (also known as VHHs). These small, compact fragments (13 kDa) corresponding to the variable domains of a llama antibody subtype are characterized by exceptional properties in terms of production, stability and propensity to bind buried epitopes inaccessible to conventional antibodies. Most VHHs can be expressed as soluble, active fragments without the formation of disulfide bridges, in a reducing environment such as the cytoplasm or cell nucleus. This feature enables them to be used as an intracellular tool for precisely neutralizing a specific interaction of a target protein without interfering with other interactions of that target.<\/h6>\n\n\n\n<p>The platform will perform llama immunization and library construction steps.<\/p>\n\n\n\n<p>Selection and screening steps, based on phage display, can be performed on recombinant proteins, transfected cells, intact cells or cell line lysates. VHHs are produced and purified from E. coli, and can be fused to various tags (c-Myc, 6-His), modified with an additional C-terminal free cysteine for directed conjugation to nanoparticles, or biotinylated in vivo.<\/p>\n\n\n\n<p>Genes encoding VHHs can also be fused to the gene of a reporter molecule such as GFP, mRFP1. The resulting constructs can be used directly as probes in living cells or for protein localization.<\/p>\n\n\n\n<p>The fully-equipped platform (gradient PCR cycler, 3 laminar flow hoods for phage display, 2 laminar flow hoods for cell culture, microincubators for 15 microtiter plates, Tecan infinite M1000, flow cytometer (3 lasers, 8 colors), AKTA purification system) can accommodate trained researchers, technicians or students to carry out the various stages once the project has been validated.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Platform mission<\/h3>\n\n\n\n<p>The mission of the&nbsp;<strong>single-domain antibody<\/strong>&nbsp;<strong>selection<\/strong>&nbsp;and&nbsp;<strong>screening<\/strong>&nbsp;platform is to support research teams in obtaining nanobodies of interest: nanobody&nbsp;<strong>selection<\/strong>&nbsp;and&nbsp;<strong>screening<\/strong>&nbsp;can be carried out on recombinant proteins, transfected cells, intact cell lines or cell extracts using phage-display technology.<\/p>\n\n\n\n<p>Nanobodies can be produced in&nbsp;<em>E. coli<\/em>&nbsp;with different tags (c-Myc, 6-His), with a C-terminal cysteine for nanoparticle attachment, or directly biotinylated&nbsp;<em>in vivo<\/em>. Genes encoding these nanobodies can also be fused to genes encoding fluorescent proteins (GFP, mRFP1, etc.). These constructs can thus be used directly as probes in living cells.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Service and platform accessibility<\/h3>\n\n\n\n<p><strong>Homemade banks:<\/strong>&nbsp;the platform already has some fifteen banks obtained from animals immunized with :<\/p>\n\n\n\n<p>&#8211; recombinant&nbsp;proteins<br>&#8211;&nbsp;human thymocytes<br>&#8211;&nbsp;biopsies of various cancers<br>&#8211;&nbsp;cells specifically transfected with a receptor<br>&#8211;&nbsp;haptens,<br>etc&#8230;.<\/p>\n\n\n\n<p><strong>Customized libraries:&nbsp;<\/strong>after selecting projects, the platform immunizes llamas and builds libraries enabling expression of Nanobodies on the bacteriophage surface.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Equipment<\/h3>\n\n\n\n<p><strong>&#8211; Gradient&nbsp;PCR<\/strong><br>&#8211;&nbsp;<strong>3&nbsp;PSM<\/strong>&nbsp;for phage display selection<br>&#8211;&nbsp;<strong>2&nbsp;PSM<\/strong>&nbsp;for cell culture<br>&#8211;&nbsp;<strong>Microplate incubators&nbsp;<\/strong>(15-microplate capacity)<br><strong>&#8211;&nbsp;Tecan&nbsp;infinite M1000<\/strong><br>&#8211;&nbsp;<strong>Cytometer&nbsp;<\/strong>(3 lasers, 8 colors)<br><strong>&#8211; AKTA purification&nbsp;system<\/strong><br>&#8211; 15-litre&nbsp;<strong>fermenter<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Labels, Funding and Partners<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.ibisa.net\/\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.univ-amu.fr\/fr\/public\/les-plateformes-technologiques\" target=\"_blank\" rel=\"noreferrer noopener\"><\/a><\/li>\n<\/ul>\n\n\n\n<p>Alumni<\/p>\n\n\n\n<p>Like others, they were part of the team.<br>Thank you to all those who have contributed to CRCM&#8217;s excellence and impact.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/termine_elise_crcm.jpg\" alt=\"\"\/><\/figure>\n\n\n\n<h5 class=\"wp-block-heading\">Elise Termine<\/h5>\n\n\n\n<h5 class=\"wp-block-heading\">Engineer<\/h5>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2025\/01\/baty_daniel_crcm_2.jpg\" alt=\"\"\/><\/figure>\n\n\n\n<h5 class=\"wp-block-heading\">Daniel Baty<\/h5>\n\n\n\n<h5 class=\"wp-block-heading\">Researcher<\/h5>\n\n\n\n<p><a href=\"https:\/\/intra-crcm.marseille.inserm.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Intranet connection<\/a><br><a href=\"https:\/\/crcm-marseille.fr\/annuaire\/\">Directory<\/a><br><a href=\"https:\/\/www.institutpaolicalmettes.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">IPC collaboration<\/a><br><a href=\"https:\/\/crcm-marseille.fr\/actualites\/\">News<\/a><br><a href=\"https:\/\/crcm-marseille.fr\/evenements\/\">Events<\/a><br><a href=\"https:\/\/crcm-marseille.fr\/en\/our-center\/partnerships-and-innovation\/\">Partnerships &amp; Innovation<\/a><br><a href=\"https:\/\/crcm-marseille.fr\/en\/terms-of-use\/\">Terms &amp; Conditions<\/a><br><a href=\"https:\/\/crcm-marseille.fr\/politique-de-confidentialite\/\">Privacy policy<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Marseille Cancer Research Center<\/h3>\n\n\n\n<p>27 Bd Le\u00ef Roure, CS 30059<br>13273 Marseille Cedex 09<\/p>\n\n\n\n<p>Tel: 04 86 97 72 00<\/p>\n\n\n\n<p><a href=\"https:\/\/crcm-marseille.fr\/en\/contact\/\">Contact us<br>How to get here<\/a><\/p>\n\n\n\n<p>Follow us<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.youtube.com\/@CRCM-marseille\" target=\"_blank\" rel=\"noreferrer noopener\">YouTube<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.linkedin.com\/company\/crcm-marseille\/\" target=\"_blank\" rel=\"noreferrer noopener\">LinkedIn<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/bsky.app\/profile\/crcm.bsky.social\" target=\"_blank\" rel=\"noreferrer noopener\">Bluesky<\/a><\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibody-platform\/\"><\/a><\/p>\n\n\n\n<p>www.crcm-marseille.fr \u00a92024 | Tous droits r\u00e9serv\u00e9s &#8211; R\u00e9alis\u00e9 par&nbsp;<a href=\"https:\/\/yesss-communication.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Yesss Communication<\/a>&nbsp;&amp;&nbsp;<a href=\"https:\/\/www.bioself-communication.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Bioself<\/a><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibody-platform\/#\"><\/a><\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/crcm-marseille.fr\/wp-content\/plugins\/sitepress-multilingual-cms\/res\/flags\/en.svg\" alt=\"English\"\/><\/figure>\n\n\n\n<p><a href=\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibody-platform\/#\"><\/a><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Nanobodies Luminy Patrick Chames Platform manager The mission of the Nanobodies platform&nbsp;is to help<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":5925,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_tec_requires_first_save":true,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","footnotes":""},"class_list":["post-5931","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Single domain antibodies | CRCM<\/title>\n<meta name=\"description\" content=\"Cancer Research Center of Marseille Platform - Nanobodies platform - Platform Manager : Patrick Chames - CRCM\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Single domain antibodies | CRCM\" \/>\n<meta property=\"og:description\" content=\"Cancer Research Center of Marseille Platform - Nanobodies platform - Platform Manager : Patrick Chames - CRCM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"CRCM\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-18T09:37:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/\",\"name\":\"Single domain antibodies | CRCM\",\"isPartOf\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847\",\"datePublished\":\"2025-01-06T08:43:54+00:00\",\"dateModified\":\"2025-11-18T09:37:11+00:00\",\"description\":\"Cancer Research Center of Marseille Platform - Nanobodies platform - Platform Manager : Patrick Chames - CRCM\",\"breadcrumb\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#primaryimage\",\"url\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847\",\"contentUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/crcm-marseille.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our technology platforms\",\"item\":\"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Single domain antibodies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#website\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/\",\"name\":\"CRCM\",\"description\":\"Marseille Cancer Research Center\",\"publisher\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\"},\"alternateName\":\"Centre de recherche en canc\u00e9rologie de Marseille\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/crcm-marseille.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\",\"name\":\"CRCM\",\"alternateName\":\"Centre de Recherche en Canc\u00e9rologie de Marseille\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png\",\"contentUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png\",\"width\":11811,\"height\":7171,\"caption\":\"CRCM\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.youtube.com\/@CRCM-marseille\",\"https:\/\/www.linkedin.com\/company\/crcm-marseille\/\",\"https:\/\/bsky.app\/profile\/crcm.bsky.social\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Single domain antibodies | CRCM","description":"Cancer Research Center of Marseille Platform - Nanobodies platform - Platform Manager : Patrick Chames - CRCM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/","og_locale":"en_US","og_type":"article","og_title":"Single domain antibodies | CRCM","og_description":"Cancer Research Center of Marseille Platform - Nanobodies platform - Platform Manager : Patrick Chames - CRCM","og_url":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/","og_site_name":"CRCM","article_modified_time":"2025-11-18T09:37:11+00:00","og_image":[{"url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/","url":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/","name":"Single domain antibodies | CRCM","isPartOf":{"@id":"https:\/\/crcm-marseille.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#primaryimage"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#primaryimage"},"thumbnailUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847","datePublished":"2025-01-06T08:43:54+00:00","dateModified":"2025-11-18T09:37:11+00:00","description":"Cancer Research Center of Marseille Platform - Nanobodies platform - Platform Manager : Patrick Chames - CRCM","breadcrumb":{"@id":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#primaryimage","url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847","contentUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-centre-de-recherche-en-cancerologie-de-marseille-crcm.webp#847"},{"@type":"BreadcrumbList","@id":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/single-domain-antibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/crcm-marseille.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Our technology platforms","item":"https:\/\/crcm-marseille.fr\/en\/our-technology-platforms\/"},{"@type":"ListItem","position":3,"name":"Single domain antibodies"}]},{"@type":"WebSite","@id":"https:\/\/crcm-marseille.fr\/en\/#website","url":"https:\/\/crcm-marseille.fr\/en\/","name":"CRCM","description":"Marseille Cancer Research Center","publisher":{"@id":"https:\/\/crcm-marseille.fr\/en\/#organization"},"alternateName":"Centre de recherche en canc\u00e9rologie de Marseille","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/crcm-marseille.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/crcm-marseille.fr\/en\/#organization","name":"CRCM","alternateName":"Centre de Recherche en Canc\u00e9rologie de Marseille","url":"https:\/\/crcm-marseille.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png","contentUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png","width":11811,"height":7171,"caption":"CRCM"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@CRCM-marseille","https:\/\/www.linkedin.com\/company\/crcm-marseille\/","https:\/\/bsky.app\/profile\/crcm.bsky.social"]}]}},"_links":{"self":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/pages\/5931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/comments?post=5931"}],"version-history":[{"count":1,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/pages\/5931\/revisions"}],"predecessor-version":[{"id":9916,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/pages\/5931\/revisions\/9916"}],"up":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/pages\/5925"}],"wp:attachment":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/media?parent=5931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}